Cargando…

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression

The epithelial–mesenchymal transition (EMT) confers mesenchymal properties on epithelial cells and has been closely associated with the acquisition of aggressive traits by epithelial cancer cells. To identify novel regulators of EMT, we carried out cDNA screens that covered 500 human kinases. Subseq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Linna, Liu, Chunping, Amato, Robert J., Chang, Jeffrey T., Du, Guangwei, Li, Wenliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279414/ https://www.ncbi.nlm.nih.gov/pubmed/25333262

Ejemplares similares

Mixed lineage kinase ZAK promotes epithelial–mesenchymal transition in cancer progression
por: Li, Linna, et al.
Publicado: (2018)

CDKL3 promotes osteosarcoma progression by activating Akt/PKB
por: He, Aina, et al.
Publicado: (2020)

CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation
por: Wang, Zheng, et al.
Publicado: (2021)

Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKB
por: He, Aina, et al.
Publicado: (2022)

CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition
por: Fan, Tao, et al.
Publicado: (2022)

Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer
por: Bednarczyk, Robert B., et al.
Publicado: (2018)

PKM2 Promotes Breast Cancer Progression by Regulating Epithelial Mesenchymal Transition
por: Xiao, Hui, et al.
Publicado: (2020)

CDKL1 promotes tumor proliferation and invasion in colorectal cancer
por: Qin, Chunzhi, et al.
Publicado: (2017)

Epithelial-mesenchymal transition in breast cancer progression and metastasis
por: Wang, Yifan, et al.
Publicado: (2011)

Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression
por: Xie, Dacheng, et al.
Publicado: (2015)

HER4 promotes the progression of colorectal cancer by promoting epithelial-mesenchymal transition
por: Jia, Xiaojing, et al.
Publicado: (2020)

Overexpression of fibrinogen-like protein 2 induces epithelial-to-mesenchymal transition and promotes tumor progression in colorectal carcinoma
por: Qin, Wen-Zheng, et al.
Publicado: (2014)

Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition
por: Xiong, Cheng, et al.
Publicado: (2021)

FOXA2 promotes the proliferation, migration and invasion, and epithelial mesenchymal transition in colon cancer
por: Wang, Baolei, et al.
Publicado: (2018)

Epithelial-mesenchymal transition as a mechanism for the progression of breast carcinoma
por: Thiery, JP, et al.
Publicado: (2011)

Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma
por: Li, Pei, et al.
Publicado: (2015)

Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas
por: Li, Hui, et al.
Publicado: (2016)

Ubiquitin ligase UBE3C promotes melanoma progression by increasing epithelial-mesenchymal transition in melanoma cells
por: Tang, Li, et al.
Publicado: (2016)

DUSP4 promotes doxorubicin resistance in gastric cancer through epithelial-mesenchymal transition
por: Kang, Xing, et al.
Publicado: (2017)

RNF8 promotes epithelial-mesenchymal transition of breast cancer cells
por: Kuang, Jingyu, et al.
Publicado: (2016)

CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial-mesenchymal transition
por: Yang, Gang, et al.
Publicado: (2021)

LOXL 2 Promotes The Epithelial–Mesenchymal Transition And Malignant Progression Of Cervical Cancer
por: Tian, Jing, et al.
Publicado: (2019)

Downregulation of 26S proteasome catalytic activity promotes epithelial-mesenchymal transition
por: Banno, Asoka, et al.
Publicado: (2016)

LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition
por: Li, Jing, et al.
Publicado: (2019)

Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells
por: Wang, Tong, et al.
Publicado: (2015)

FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells
por: Yang, Hui, et al.
Publicado: (2015)

IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling
por: Hu, Wei, et al.
Publicado: (2019)

Epithelial-mesenchymal transition in glioblastoma progression
por: IWADATE, YASUO
Publicado: (2016)

SMYD3 promotes the epithelial–mesenchymal transition in breast cancer
por: Fenizia, Claudio, et al.
Publicado: (2019)

Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation
por: Huo, Xiongwei, et al.
Publicado: (2015)

Complex CDKL5 translational regulation and its potential role in CDKL5 deficiency disorder
por: Ruggiero, Valeria, et al.
Publicado: (2023)

Fatty Acid Synthase Mediates the Epithelial-Mesenchymal Transition of Breast Cancer Cells
por: Li, Junqin, et al.
Publicado: (2014)

Small breast epithelial mucin promotes the invasion and metastasis of breast cancer cells via promoting epithelial-to-mesenchymal transition
por: Li, Qiu-Hua, et al.
Publicado: (2020)

CircLMNB1 promotes colorectal cancer by regulating cell proliferation, apoptosis and epithelial-mesenchymal transition
por: He, Chunping, et al.
Publicado: (2019)

NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
por: Qin, Shan, et al.
Publicado: (2017)

Novel CDKL5 mutations were found in patients in China: retrospective investigation in cases of CDKL5-related disorders
por: Yan, Yumei, et al.
Publicado: (2020)

Suppression of CUL4A attenuates TGF-β1-induced epithelial-to-mesenchymal transition in breast cancer cells
por: Wang, Yunshan, et al.
Publicado: (2017)

Suppression of CUL4A attenuates TGF-β1-induced epithelial-to-mesenchymal transition in breast cancer cells
por: Wang, Yunshan, et al.
Publicado: (2017)

Suppression of CUL4A attenuates TGF-β1-induced epithelial-to-mesenchymal transition in breast cancer cells
por: Wang, Yunshan, et al.
Publicado: (2023)

Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition
por: Dong, Zhizhen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m6meijnbd2ao1ireuks5ia6llm